Notwithstanding the other provisions of Group 1, Subchapter 1, Chapter 2 of Part I (commencing with Section 950) of Title 17 relating to the production and distribution of biologics, the Director may at his discretion waive such regulations for research projects approved by the Director. The waiver shall be for a specific period of time and subject to all conditions which the Director finds necessary to protect the public health.

Note: Authority cited: Section 102 and 208, Health and Safety Code. Reference: Sections 1600-1616, Health and Safety code.

History

1. New Article 13 (Section 1028) filed 3-5-76; effective thirtieth day thereafter (Register 76, No. 10).